Organization
Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center
1 abstract
Abstract
Phase II study of nivolumab (nivo) in combination with relatlimab (rela) in patients (pts) with active melanoma brain metastases (MBM).Org: University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Texas - M. D. Anderson Cancer Center, Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center,